Health News
Date: Apr-19-2013
Since implementing a nationwide human papillomavirus (HPV) vaccination program five years ago for females between the ages of 12 and 26 years, Australia has seen a significant decline in the number of cases of genital warts, according to new research in the journal BMJ. Among the girls within the age range for the vaccine, Australia saw a 59% decline in genital warts cases - just within the first two years of the start of the program in 2007...
Date: Apr-19-2013
Most of the deaths that result from underage drinking are not traffic-related, warns Mothers Against Drunk Driving (MADD). Approximately 4,700 kids die each year because of underage alcohol use, according to the Substance Abuse and Mental Health Services Administration (SAMSHA), and 68% of those deaths are not related to traffic accidents, the new analysis revealed. SAMHSA said in a previous report that over a quarter of the U.S. population who are under 21 (the legal drinking age) are consuming alcohol anyway...
Date: Apr-19-2013
Men, want to increase your chances of becoming a dad? Then wearing a kilt, without underwear, could do it for you...
Date: Apr-19-2013
Adaptive Clinical Trial: Translation in Action - How statistics can effectively couple clinical trials & personalised medicine in Oncology. Clinical trials run by pharmaceutical and biotech companies have undergone major changes as a result of implementing adaptive designs to tailor a trial as it progresses. Supporters of Adaptive Clinical Trials argue they achieve a real reduction in costs and can significantly improve the overall clinical accuracy...
Date: Apr-19-2013
SMi's much anticipated 3rd Biobanking conference returns on 24th-25th May and is already proving to be very popular with esteemed industry professionals. "Use of human biosamples is critical in enabling the discovery and validation of new targets and biomarkers"� Paul Whittaker, Director, Novartis - SPEAKER AT BIOBANKING 2013 "Biobanking has propelled research and researchers in a new era where innovation, reciprocity and universalism meet".... - Ma'n H...
Date: Apr-19-2013
Despite the fact every year millions of people discover they have type 2 diabetes, we still don't know exactly what causes the disease. Now researchers in the US suggest it may be linked to the amount of melatonin a person secretes: in a JAMA study published online this month they show participants who secreted the least melatonin into the bloodstream during sleep had double the risk of developing type 2 diabetes. Melatonin is a hormone that helps to control other hormones and our day-night cycle or circadian rhythm...
Date: Apr-19-2013
Every year 43,000 people die following osteoporotic fractures; reports show that European healthcare systems are not treating people at risk; burden and costs will rise dramatically by 2025. Two landmark multi-stakeholder reports launched this week - Osteoporosis in the European Union and the Scorecard for Osteoporosis in Europe - describe and compare the epidemiology, burden, and management of osteoporosis and fractures in all 27 member states of the European Union (EU). Twenty-two million women and 5.5 million men in the EU are estimated to have osteoporosis, resulting in 3...
Date: Apr-19-2013
MIT engineers find that in the earliest stages of arthritis, high-impact exercise may worsen cartilage damage Osteoarthritis, which affects at least 20 percent of adults in the United States, leads to deterioration of cartilage, the rubbery tissue that prevents bones from rubbing together. By studying the molecular properties of cartilage, MIT engineers have now discovered how the earliest stages of arthritis make the tissue more susceptible to damage from physical activities such as running or jumping...
Date: Apr-19-2013
New guidelines for the diagnosis and classification of inflammatory bowel disease (IBD) in children, which are currently in press,1 should help overcome current diagnostic uncertainties and ensure treatment is optimised as early as possible...
Date: Apr-19-2013
Aclidinium / formoterol fixed dose combinations twice daily show statistically significant improvements in the two co-primary endpoints in the first pivotal COPD study. A second pivotal Phase III study is still ongoing, results expected in coming weeks Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc...